drugset / Trial / NCT01043458
Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
A study to investigate the process by which ABT-126 is absorbed, distributed, metabolized and eliminated by the body of stable schizophrenic volunteers receiving treatment with an atypical antipsychotic.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-126 | Small molecule | — | — |